Home/Filings/4/0001630998-17-000002
4//SEC Filing

INC Research Holdings, Inc. 4

Accession 0001630998-17-000002

CIK 0001610950operating

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 4:02 PM ET

Size

10.8 KB

Accession

0001630998-17-000002

Insider Transaction Report

Form 4
Period: 2017-01-27
Gibertini Michael
President Clinical Development
Transactions
  • Award

    Class A Common Stock

    2017-01-27+10,56757,369 total
  • Award

    Performance Restricted Stock Units

    2017-01-27+15,85115,851 total
    Class A Common Stock, par value $0.01 per share (15,851 underlying)
Footnotes (2)
  • [F1]Represents an award of restricted stock units which vests in three equal annual installments beginning on January 27, 2018, subject to continued employment.
  • [F2]Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of INC Research Holdings, Inc. (the "Issuer") common stock. The PRSUs vest up to one-third upon the achievement of adjusted diluted net income earnings per share ("EPS") goals during each of 2017, 2018 and 2019. EPS will be as reported in the Issuer's Forms 10-K or other reports publicly filed with the Commission. Vesting of target PRSUs may accelerate in certain circumstances, including if the holder's employment is terminated without cause or the holder resigns for good reason under certain circumstances in connection with a change in control of the Issuer during any performance period.

Issuer

INC Research Holdings, Inc.

CIK 0001610950

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001610950

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:02 PM ET
Size
10.8 KB